Form 13-F position report

ONCONOVA THERAPEUTICS INC COM

Reported by Alyeska Investment Group L P

TRAW CUSIP 68232V801 Manager CIK 0001453072

Reported 0 shares, down 250,000 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q4 2021
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 2 Through Q4 2021

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 0
2024-12-31 1036420
2025-03-31 121049
2025-06-30 77892
2025-09-30 0
2026-06-30 138618
2026-09-30 97606

Quarterly position history

How this manager's reported quarter-end position changed over time.

7 quarters
Quarterly reported position history for ONCONOVA THERAPEUTICS INC COM held by Alyeska Investment Group L P.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Unchanged 164,376 0 (0.0%) < 0.01% $97,606 2026-11-16
Q2 2026 New 164,376 +164,376 (0.0%) < 0.01% $138,618 2026-08-14
Q3 2025 Reduced 0 -52,630 (-100.0%) 0 $0 2025-11-17
Q2 2025 Unchanged 52,630 0 (0.0%) < 0.01% $77,892 2025-08-14
Q1 2025 Reduced 52,630 -64,084 (-54.9%) < 0.01% $121,049 2025-05-15
Q4 2024 New 116,714 +116,714 (0.0%) < 0.01% $1,036,420 2025-02-14
Q4 2021 Reduced 0 -250,000 (-100.0%) 0 $0 2022-02-14
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

44 managers reported ONCONOVA THERAPEUTICS INC COM for Q4 2021.

Managers reporting ONCONOVA THERAPEUTICS INC COM in Q4 2021.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Reduced 846,339 -13,571 < 0.01% $2,159,000 3 qtrs
TWO SIGMA ADVISERS LP New 295,312 +295,312 < 0.01% $753,000 3 qtrs
BlackRock Inc Reduced 248,881 -2,229 < 0.01% $635,000 3 qtrs
GEODE CAPITAL MANAGEMENT LLC Reduced 162,969 -14,461 < 0.01% $415,000 3 qtrs
Anson Funds Management LP New 145,290 +145,290 0.04% $370,000 1 qtr
RENAISSANCE TECHNOLOGIES LLC New 133,627 +133,627 < 0.01% $341,000 1 qtr
Hudson Bay Capital Management LP Reduced 90,922 -74,762 < 0.01% $232,000 2 qtrs
SUSQUEHANNA FUNDAMENTAL INVESTMENTS LLC Added 72,167 +46,337 < 0.01% $184,000 3 qtrs
TWO SIGMA INVESTMENTS LP New 67,861 +67,861 < 0.01% $173,000 1 qtr
GSA CAPITAL PARTNERS LLP Reduced 57,799 -182,859 0.02% $147,000 2 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2021
Filed
February 14, 2022
Filing type
13F-HR
Position type
COM NEW

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.